VA Palo Alto Healthcare System (VAPAHCS)
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for VA Palo Alto Healthcare System (VAPAHCS) based on listed parameters only.
The articles listed below published by authors from VA Palo Alto Healthcare System (VAPAHCS), organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
1 | 0.07 |
Analytical Chemistry |
1 | 0.25 |
Annals of Internal Medicine |
4 | 0.38 |
Annals of the Rheumatic Diseases |
2 | 0.09 |
Archives of Physical Medicine and Rehabilitation |
2 | 0.24 |
Cell |
4 | 0.08 |
Cell Metabolism |
2 | 0.05 |
Cell Stem Cell |
1 | 0.01 |
Circulation |
1 | 0.39 |
Developmental Cell |
2 | 0.07 |
Hepatology |
2 | 0.39 |
JAMA Pediatrics |
1 | 0.06 |
JAMA Psychiatry |
1 | 0.03 |
Journal of Biological Chemistry |
2 | 0.41 |
Journal of Bone and Joint Surgery-American Volume |
1 | 0.25 |
Journal of Clinical Oncology |
1 | 0.07 |
Journal of Hepatology |
1 | 0.04 |
Journal of the American Academy of Dermatology |
1 | 0.39 |
Journal of the American College of Cardiology |
2 | 0.08 |
Journal of the American Geriatrics Society |
4 | 0.38 |
Journal of the American Society of Nephrology |
2 | 0.04 |
Molecular Psychiatry |
1 | 0.36 |
Nature |
3 | 0.03 |
Nature Cell Biology |
1 | 0.02 |
Nature Communications |
12 | 1.50 |
Nature Genetics |
4 | 0.08 |
Nature Immunology |
1 | 0.03 |
Nature Materials |
1 | 0.03 |
Nature Medicine |
1 | 0.08 |
Nature Methods |
1 | 0.05 |
Ophthalmology |
2 | 0.17 |
PLOS Biology |
1 | 0.06 |
Proceedings of the National Academy of Sciences of the United States of America |
2 | 0.16 |
Proceedings of the Royal Society B |
1 | 0.04 |
Science Translational Medicine |
1 | 0.25 |
The BMJ |
1 | 0.03 |
The New England Journal of Medicine |
2 | 0.04 |
Water Research |
1 | 0.04 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.